Area of research
Oncology · Hepatology
Research interest
Research interests include CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers, Hepatocellular Carcinoma Treatment and Prognosis, and Immunotherapy and Immune Responses.
CAR-T triggers TAM reeducation and adaptive anti-tumor response via TREM2 deficiency or CD40 agonist
<b>PD-L1</b><b>-</b><b>Binding Antigen Presenters: Redirecting Vaccine-Induced Antibodies for Tumor-Agnostic Immunotherapy</b><b></b>
PD‐L1‐Binding Antigen Presenters: Redirecting Vaccine‐Induced Antibodies for Cancer Immunotherapy
Elevated SLC1A5 associated with poor prognosis and therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma
Moderate expression of CD39 in GPC3-CAR-T cells shows high efficacy against hepatocellular carcinoma
TREM2+ macrophages suppress CD8+ T-cell infiltration after transarterial chemoembolisation in hepatocellular carcinoma
Micro‐Engineered Organoid‐on‐a‐Chip Based on Mesenchymal Stromal Cells to Predict Immunotherapy Responses of HCC Patients
Enhancement of CAR‐T cell activity against cholangiocarcinoma by simultaneous knockdown of six inhibitory membrane proteins
Doxorubicin-Loaded UiO-66/Bi<sub>2</sub>S<sub>3</sub> Nanocomposite-Enhanced Synergistic Transarterial Chemoembolization and Photothermal Therapy against Hepatocellular Carcinoma
Anti-PD-L1 antibody enhances curative effect of cryoablation via antibody-dependent cell-mediated cytotoxicity mediating PD-L1highCD11b+ cells elimination in hepatocellular carcinoma
Distinctive microbiota of delayed healing of oral mucositis after radiotherapy of nasopharyngeal carcinoma
The CD39+ HBV surface protein-targeted CAR-T and personalized tumor-reactive CD8+ T cells exhibit potent anti-HCC activity
Extracellular vesicles engineered with valency-controlled DNA nanostructures deliver CRISPR/Cas9 system for gene therapy
High-affinity neoantigens correlate with better prognosis and trigger potent antihepatocellular carcinoma (HCC) activity by activating CD39 <sup>+</sup> CD8 <sup>+</sup> T cells